US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

476.42

-0.01000.00%

Post-market: 476.500.0800+0.02%18:13 EDT

Volume:4.02M

Turnover:1.91B

Market Cap:23.61B

PE:45.29

High:481.17

Open:477.43

Low:465.02

Close:476.43

52wk High:625.99

52wk Low:228.00

Shares:49.56M

Float Shares:48.15M

Volume Ratio:6.82

T/O Rate:8.35%

Dividend:0.80

Dividend Rate:0.17%

EPS(TTM):10.52

EPS(LYR):10.52

ROE:25.75%

ROA:11.87%

PB:10.60

PE(LYR):45.29

Loading ...

Overview Company News Filings

Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting

Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion

Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress

Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting

Carpenter Technology Director Steven E. Karol disposes of 2,000 common shares worth $975,478.80

Carpenter Technology director John Anastasio Hart disposes of 250 common shares worth $115,470.33

Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026

Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting

Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology

Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting

PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure

Navigating the Pitfalls of Offshore Trusts as CRS 2.0 Implementation Approaches

Carpenter Technology: This Stock Will Melt Up -- Barron's

Analysts’ Top Industrial Goods Picks: Carpenter Technology (CRS), Brambles (BMBLF)

Carpenter Technology: This Stock Will Melt Up -- Barrons.com

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/CRS/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","market":"US","secType":"STK","nameCN":"Carpenter Technology","latestPrice":476.42,"timestamp":1788206400000,"preClose":476.43,"halted":0,"volume":4021121,"hourTrading":{"tag":"盘后","latestPrice":476.5,"preClose":476.42,"latestTime":"18:13 EDT","volume":1058545,"amount":504308113.4544,"timestamp":1788214380570,"change":0.08,"changeRate":0.000168,"amplitude":0.028684},"delay":0,"changeRate":-0.000020989442310498718,"floatShares":48145238,"shares":49558566,"eps":10.52,"marketStatus":"Post-Mkt","change":-0.01,"latestTime":"08-31 18:33:34 EDT","open":477.43,"high":481.165,"low":465.02,"amount":1913664110.21994,"amplitude":0.033887,"askPrice":490,"askSize":2,"bidPrice":466,"bidSize":1,"shortable":3,"etf":0,"ttmEps":10.52,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":476.43,"dividendRate":0.001679,"preHourTrading":{"tag":"盘前","latestPrice":482,"preClose":476.43,"latestTime":"09:29 EDT","volume":16,"amount":7677.97024,"timestamp":1788182995600,"change":5.57,"changeRate":0.011691,"amplitude":0.020989},"postHourTrading":{"tag":"盘后","latestPrice":476.5,"preClose":476.42,"latestTime":"18:13 EDT","volume":1058545,"amount":504308113.4544,"timestamp":1788214380570,"change":0.08,"changeRate":0.000168,"amplitude":0.028684},"volumeRatio":6.82105,"impliedVol":0.4927,"impliedVolPercentile":0.4143},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRS\",,,,,undefined,":{"symbol":"CRS","floatShares":48145238,"roa":"11.87%","roe":"25.75%","lyrEps":10.52,"volumeRatio":6.82105,"shares":49558566,"dividePrice":0.8,"high":481.165,"amplitude":0.033887,"preClose":476.43,"low":465.02,"week52Low":228,"pbRate":"10.60","psRate":"7.56","week52High":625.985,"institutionHeld":0.9356,"latestPrice":476.42,"committee":-0.333333,"eps":10.52,"divideRate":0.001679,"volume":4021121,"delay":0,"ttmEps":10.52,"open":477.43,"prevYearClose":314.84,"prevWeekClose":476.43,"prevMonthClose":519.66,"prevQuarterClose":616.84,"fiveDayClose":477.1,"twentyDayClose":543.49,"sixtyDayClose":492.62,"dividendPayoutRate":0.0755287009063444,"dividendFrequency":"Q","dividendGrowthYears":10,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.010954022070790322},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRS\",params:#limit:5,,,undefined,":[{"date":"2026-08-25","symbol":"CRS","amount":0.2,"announcedDate":"2026-08-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-25","defaultRemindTime":1787664600000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-08-25","currency":"USD","dateTimestamp":1787630400000,"payDate":"2026-09-03"},{"date":"2026-07-30","symbol":"CRS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":3.03,"defaultRemindTime":1785398400000,"name":null,"time":"Pre-MKt","dateTimestamp":1785384000000,"actualEps":null},{"market":"US","date":"2026-04-29","symbol":"CRS","fiscalQuarterEnding":"2026/03","expectedEps":2.59,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"pre","actualEps":2.77},{"date":"2026-04-28","symbol":"CRS","amount":0.2,"announcedDate":"2026-04-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-04-28","defaultRemindTime":1777383000000,"name":"卡朋特科技","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-04","payableDate":"2026-04-28","currency":"USD","dateTimestamp":1777348800000,"payDate":"2026-06-04"},{"market":"US","date":"2026-01-29","symbol":"CRS","fiscalQuarterEnding":"2025/12","expectedEps":2.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1769662800000,"reportTimeType":"pre","actualEps":2.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRS\",market:\"US\",,,undefined,":[{"executeDate":"2016-10-21","recordDate":"2016-10-25","paymentDate":"2016-12-01","value":0.18,"currency":"USD"},{"executeDate":"2017-02-03","recordDate":"2017-02-07","paymentDate":"2017-03-02","value":0.18,"currency":"USD"},{"executeDate":"2017-04-28","recordDate":"2017-05-02","paymentDate":"2017-06-01","value":0.18,"currency":"USD"},{"executeDate":"2017-08-18","recordDate":"2017-08-22","paymentDate":"2017-09-07","value":0.18,"currency":"USD"},{"executeDate":"2017-10-23","recordDate":"2017-10-24","paymentDate":"2017-12-07","value":0.18,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.0909,"buy":0.7273,"hold":0.1818,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7273,"analysts":11,"updateTime":1780891200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRS","date":"2026-08-28","current":44.681559,"percent":0.830343,"low":-450.702526,"twenty":-13.465718,"median":32.784266,"eighty":43.750874,"high":137.40172,"avg":3.074663,"sd":101.412476,"marketCap":24312441308},"quantilePoints":[{"date":"2021-09-03","current":-6.975601,"twenty":-6.333208,"median":14.178684,"eighty":34.11215,"marketCap":1601597904},{"date":"2021-09-10","current":-6.619703,"twenty":-6.445817,"median":14.149507,"eighty":34.11215,"marketCap":1519883725},{"date":"2021-09-17","current":-6.609235,"twenty":-6.563514,"median":14.138554,"eighty":34.11215,"marketCap":1517480367},{"date":"2021-09-24","current":-6.841616,"twenty":-6.60093,"median":14.085675,"eighty":34.11215,"marketCap":1570834919},{"date":"2021-10-01","current":-7.170298,"twenty":-6.621574,"median":14.055464,"eighty":34.11215,"marketCap":1646300367},{"date":"2021-10-08","current":-6.973507,"twenty":-6.672026,"median":13.993043,"eighty":34.11215,"marketCap":1601117232},{"date":"2021-10-15","current":-7.048874,"twenty":-6.705955,"median":13.980331,"eighty":34.11215,"marketCap":1618421411},{"date":"2021-10-22","current":-6.705537,"twenty":-6.80716,"median":13.928396,"eighty":34.11215,"marketCap":1539591262},{"date":"2021-10-29","current":-7.541903,"twenty":-6.825286,"median":13.903764,"eighty":34.05528,"marketCap":1488017462},{"date":"2021-11-05","current":-8.00106,"twenty":-6.851665,"median":13.83802,"eighty":34.05528,"marketCap":1578609199},{"date":"2021-11-12","current":-8.31612,"twenty":-6.907352,"median":13.791799,"eighty":34.05528,"marketCap":1640770550},{"date":"2021-11-19","current":-7.480845,"twenty":-6.929962,"median":13.765103,"eighty":34.05528,"marketCap":1475970689},{"date":"2021-11-26","current":-7.146246,"twenty":-6.978113,"median":13.706435,"eighty":34.05528,"marketCap":1409954370},{"date":"2021-12-03","current":-6.884917,"twenty":-6.981881,"median":13.63571,"eighty":34.05528,"marketCap":1358394179},{"date":"2021-12-10","current":-7.224401,"twenty":-6.994861,"median":13.57876,"eighty":33.936368,"marketCap":1425374240},{"date":"2021-12-17","current":-7.458864,"twenty":-7.02802,"median":13.539792,"eighty":33.496912,"marketCap":1471633850},{"date":"2021-12-23","current":-7.077861,"twenty":-7.039534,"median":13.519346,"eighty":33.496912,"marketCap":1396461984},{"date":"2021-12-31","current":-7.12915,"twenty":-7.066051,"median":13.45606,"eighty":33.496912,"marketCap":1406581273},{"date":"2022-01-07","current":-7.932675,"twenty":-7.091184,"median":13.431482,"eighty":33.400404,"marketCap":1565116813},{"date":"2022-01-14","current":-7.974195,"twenty":-7.129269,"median":13.381664,"eighty":33.107884,"marketCap":1573308619},{"date":"2022-01-21","current":-7.114496,"twenty":-7.147711,"median":13.368154,"eighty":32.88775,"marketCap":1403690048},{"date":"2022-01-28","current":-7.029015,"twenty":-7.160249,"median":13.326394,"eighty":32.776514,"marketCap":1386824565},{"date":"2022-02-04","current":-9.851468,"twenty":-7.191153,"median":13.275258,"eighty":32.442808,"marketCap":1395953072},{"date":"2022-02-11","current":-13.193201,"twenty":-7.232126,"median":13.242532,"eighty":32.193446,"marketCap":1869476573},{"date":"2022-02-18","current":-12.968375,"twenty":-7.26807,"median":13.187778,"eighty":31.47225,"marketCap":1837618722},{"date":"2022-02-25","current":-13.165949,"twenty":-7.299087,"median":13.169615,"eighty":17.092068,"marketCap":1865615015},{"date":"2022-03-04","current":-12.474439,"twenty":-7.319765,"median":13.0994,"eighty":16.85449,"marketCap":1767627991},{"date":"2022-03-11","current":-11.871496,"twenty":-7.421217,"median":13.034267,"eighty":16.715734,"marketCap":1682191029},{"date":"2022-03-18","current":-12.954749,"twenty":-7.462036,"median":12.879448,"eighty":16.303153,"marketCap":1835687944},{"date":"2022-03-25","current":-14.504686,"twenty":-7.515082,"median":12.802432,"eighty":16.256541,"marketCap":2055314032},{"date":"2022-04-01","current":-14.766983,"twenty":-7.582461,"median":12.767221,"eighty":16.18078,"marketCap":2092481524},{"date":"2022-04-08","current":-13.779111,"twenty":-7.620731,"median":12.594144,"eighty":16.089337,"marketCap":1952500061},{"date":"2022-04-14","current":-14.463809,"twenty":-7.6687,"median":12.549841,"eighty":15.995398,"marketCap":2049521696},{"date":"2022-04-22","current":-13.768892,"twenty":-7.706324,"median":12.48713,"eighty":15.944544,"marketCap":1951051977},{"date":"2022-04-29","current":-16.93868,"twenty":-7.80714,"median":12.285392,"eighty":15.831326,"marketCap":1842928364},{"date":"2022-05-06","current":-15.430259,"twenty":-7.890014,"median":11.834154,"eighty":15.671927,"marketCap":1678812166},{"date":"2022-05-13","current":-14.732062,"twenty":-7.939552,"median":11.674871,"eighty":15.625444,"marketCap":1602848324},{"date":"2022-05-20","current":-14.403697,"twenty":-7.995198,"median":11.60329,"eighty":15.577684,"marketCap":1567122187},{"date":"2022-05-27","current":-16.023336,"twenty":-8.084816,"median":11.482348,"eighty":15.550272,"marketCap":1743338946},{"date":"2022-06-03","current":-15.535225,"twenty":-8.185212,"median":11.217373,"eighty":15.538022,"marketCap":1690232525},{"date":"2022-06-10","current":-14.314949,"twenty":-8.336657,"median":10.984637,"eighty":15.511601,"marketCap":1557466474},{"date":"2022-06-17","current":-13.130172,"twenty":-8.723615,"median":10.774911,"eighty":15.479597,"marketCap":1428562708},{"date":"2022-06-24","current":-13.121297,"twenty":-8.876021,"median":10.579851,"eighty":15.401151,"marketCap":1427597137},{"date":"2022-07-01","current":-12.158388,"twenty":-9.25749,"median":10.54371,"eighty":15.37648,"marketCap":1322832653},{"date":"2022-07-08","current":-11.577093,"twenty":-9.332781,"median":10.464198,"eighty":15.337478,"marketCap":1259587734},{"date":"2022-07-15","current":-12.25601,"twenty":-9.427235,"median":10.322041,"eighty":15.309248,"marketCap":1333453937},{"date":"2022-07-22","current":-12.517815,"twenty":-9.521691,"median":10.228073,"eighty":15.261138,"marketCap":1361938290},{"date":"2022-07-29","current":-31.602302,"twenty":-9.546869,"median":10.170246,"eighty":15.207938,"marketCap":1551673046},{"date":"2022-08-05","current":-33.490181,"twenty":-9.672279,"median":10.085916,"eighty":15.174821,"marketCap":1644367889},{"date":"2022-08-12","current":-36.675976,"twenty":-9.788172,"median":9.92623,"eighty":15.065191,"marketCap":1800790437},{"date":"2022-08-19","current":-37.521589,"twenty":-9.968368,"median":9.772689,"eighty":15.019966,"marketCap":1842310002},{"date":"2022-08-26","current":-36.754563,"twenty":-10.063588,"median":9.527906,"eighty":15.004808,"marketCap":1804649058},{"date":"2022-09-02","current":-32.101215,"twenty":-10.201618,"median":9.245021,"eighty":14.970589,"marketCap":1576169667},{"date":"2022-09-09","current":-35.308385,"twenty":-10.36067,"median":8.847464,"eighty":14.926403,"marketCap":1733641721},{"date":"2022-09-16","current":-35.446117,"twenty":-10.675455,"median":8.541465,"eighty":14.875756,"marketCap":1740404325},{"date":"2022-09-23","current":-32.789871,"twenty":-11.559344,"median":8.289418,"eighty":14.84909,"marketCap":1609982685},{"date":"2022-09-30","current":-30.635361,"twenty":-11.845143,"median":7.640878,"eighty":14.814116,"marketCap":1504196244},{"date":"2022-10-07","current":-33.389986,"twenty":-12.192577,"median":7.303864,"eighty":14.792584,"marketCap":1639448315},{"date":"2022-10-14","current":-32.927603,"twenty":-12.250128,"median":7.00933,"eighty":14.766319,"marketCap":1616745289},{"date":"2022-10-21","current":-35.701903,"twenty":-12.401516,"median":6.901712,"eighty":14.727355,"marketCap":1752963446},{"date":"2022-10-28","current":-42.377552,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1745955133},{"date":"2022-11-04","current":-45.587616,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1878209781},{"date":"2022-11-11","current":-46.998633,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1936343692},{"date":"2022-11-18","current":-48.197998,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1985757516},{"date":"2022-11-25","current":-48.150964,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1983819719},{"date":"2022-12-02","current":-50.385075,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":2075865079},{"date":"2022-12-09","current":-46.234332,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1904854490},{"date":"2022-12-16","current":-44.01198,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1813293580},{"date":"2022-12-23","current":-44.447044,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1831218202},{"date":"2022-12-30","current":-43.435815,"twenty":-12.462176,"median":6.853568,"eighty":14.70833,"marketCap":1789555566},{"date":"2023-01-06","current":-45.846303,"twenty":-12.595028,"median":6.777102,"eighty":14.682147,"marketCap":1888867664},{"date":"2023-01-13","current":-52.442808,"twenty":-12.732349,"median":6.618507,"eighty":14.664985,"marketCap":2160643699},{"date":"2023-01-20","current":-52.066537,"twenty":-12.847955,"median":6.510889,"eighty":14.63597,"marketCap":2145141323},{"date":"2023-01-27","current":-425.668309,"twenty":-12.960199,"median":6.414599,"eighty":14.624201,"marketCap":2383742530},{"date":"2023-02-03","current":-441.347178,"twenty":-13.077381,"median":6.343798,"eighty":14.600968,"marketCap":2471544198},{"date":"2023-02-10","current":-427.400781,"twenty":-13.129156,"median":6.274928,"eighty":14.600968,"marketCap":2393444372},{"date":"2023-02-17","current":-435.283527,"twenty":-13.338316,"median":6.083249,"eighty":14.593148,"marketCap":2437587752},{"date":"2023-02-24","current":-409.729569,"twenty":-13.478662,"median":6.020944,"eighty":14.555551,"marketCap":2294485585},{"date":"2023-03-03","current":-450.702526,"twenty":-13.745087,"median":5.786317,"eighty":14.527768,"marketCap":2523934144},{"date":"2023-03-10","current":-390.759003,"twenty":-13.855323,"median":5.616366,"eighty":14.502617,"marketCap":2188250417},{"date":"2023-03-17","current":-332.547952,"twenty":-13.950796,"median":5.451701,"eighty":14.489684,"marketCap":1862268533},{"date":"2023-03-24","current":-355.156709,"twenty":-14.107889,"median":5.340195,"eighty":14.489684,"marketCap":1988877569},{"date":"2023-03-31","current":-387.727177,"twenty":-14.303115,"median":5.127756,"eighty":14.48846,"marketCap":2171272194},{"date":"2023-04-06","current":-360.354124,"twenty":-14.415719,"median":4.983031,"eighty":14.48846,"marketCap":2017983094},{"date":"2023-04-14","current":-391.538615,"twenty":-14.49651,"median":4.827685,"eighty":14.490909,"marketCap":2192616246},{"date":"2023-04-21","current":-410.422557,"twenty":-14.720939,"median":4.327125,"eighty":14.471026,"marketCap":2298366322},{"date":"2023-04-28","current":126.995225,"twenty":-14.772654,"median":-6.134077,"eighty":14.461866,"marketCap":2616101641},{"date":"2023-05-05","current":117.180335,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2413914899},{"date":"2023-05-12","current":116.75611,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2405175867},{"date":"2023-05-19","current":111.712548,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2301278484},{"date":"2023-05-26","current":108.153773,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2227967714},{"date":"2023-06-02","current":108.884382,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2243018269},{"date":"2023-06-09","current":122.176761,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2516841279},{"date":"2023-06-16","current":122.624554,"twenty":-14.774545,"median":-6.155542,"eighty":14.451408,"marketCap":2526065813},{"date":"2023-06-23","current":123.001643,"twenty":-14.776435,"median":-6.181961,"eighty":14.441982,"marketCap":2533833842},{"date":"2023-06-30","current":131.109051,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2700846457},{"date":"2023-07-07","current":126.136193,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2598405580},{"date":"2023-07-14","current":137.40172,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2830475435},{"date":"2023-07-21","current":135.304164,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2787265776},{"date":"2023-07-28","current":50.68501,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2858634539},{"date":"2023-08-04","current":49.652027,"twenty":-14.780872,"median":-6.20838,"eighty":14.470691,"marketCap":2800374324},{"date":"2023-08-11","current":49.565945,"twenty":-14.780872,"median":-6.20838,"eighty":14.471362,"marketCap":2795519306},{"date":"2023-08-18","current":49.809336,"twenty":-14.780872,"median":-6.20838,"eighty":14.502171,"marketCap":2809246524},{"date":"2023-08-25","current":50.051843,"twenty":-14.780872,"median":-6.20838,"eighty":14.549981,"marketCap":2822923955},{"date":"2023-09-01","current":54.243761,"twenty":-14.78531,"median":-6.224066,"eighty":14.53565,"marketCap":3059348110},{"date":"2023-09-08","current":53.741424,"twenty":-14.78531,"median":-6.224066,"eighty":14.597174,"marketCap":3031016290},{"date":"2023-09-15","current":60.046622,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3386629482},{"date":"2023-09-22","current":59.578929,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3360251581},{"date":"2023-09-29","current":59.067931,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3331431281},{"date":"2023-10-06","current":56.634193,"twenty":-14.78531,"median":-6.224066,"eighty":14.633502,"marketCap":3194168496},{"date":"2023-10-13","current":58.444339,"twenty":-14.78531,"median":-6.224066,"eighty":14.683568,"marketCap":3296260745},{"date":"2023-10-20","current":53.905982,"twenty":-14.78531,"median":-6.224066,"eighty":14.76393,"marketCap":3040297403},{"date":"2023-10-27","current":29.413584,"twenty":-14.798622,"median":-6.243054,"eighty":14.799544,"marketCap":3153136205},{"date":"2023-11-03","current":30.931489,"twenty":-14.798622,"median":-6.243054,"eighty":15.01852,"marketCap":3315855601},{"date":"2023-11-10","current":30.439345,"twenty":-14.798622,"median":-6.243054,"eighty":15.226052,"marketCap":3263097750},{"date":"2023-11-17","current":30.770507,"twenty":-14.798622,"median":-6.243054,"eighty":15.307189,"marketCap":3298598360},{"date":"2023-11-24","current":31.53402,"twenty":-14.798622,"median":-6.243054,"eighty":15.385027,"marketCap":3380446989},{"date":"2023-12-01","current":32.568903,"twenty":-14.798622,"median":-6.243054,"eighty":15.486556,"marketCap":3491386396},{"date":"2023-12-08","current":29.648234,"twenty":-14.794185,"median":-6.241403,"eighty":15.536881,"marketCap":3178290737},{"date":"2023-12-15","current":31.27645,"twenty":-14.794185,"median":-6.241403,"eighty":15.632081,"marketCap":3352835404},{"date":"2023-12-22","current":32.449317,"twenty":-14.794185,"median":-6.241403,"eighty":15.801544,"marketCap":3478566731},{"date":"2023-12-29","current":32.909264,"twenty":-14.798622,"median":-6.243054,"eighty":15.948971,"marketCap":3527873134},{"date":"2024-01-05","current":31.235054,"twenty":-14.79951,"median":-6.24759,"eighty":16.017891,"marketCap":3348397827},{"date":"2024-01-12","current":30.857897,"twenty":-14.79951,"median":-6.24759,"eighty":16.17357,"marketCap":3307966577},{"date":"2024-01-19","current":30.315159,"twenty":-14.800397,"median":-6.252126,"eighty":16.273067,"marketCap":3249785021},{"date":"2024-01-26","current":21.233342,"twenty":-14.79951,"median":-6.24759,"eighty":16.768529,"marketCap":3049107961},{"date":"2024-02-02","current":20.907358,"twenty":-14.79951,"median":-6.24759,"eighty":16.918792,"marketCap":3002296634},{"date":"2024-02-09","current":21.609317,"twenty":-14.79951,"median":-6.24759,"eighty":17.196305,"marketCap":3103097903},{"date":"2024-02-16","current":22.789571,"twenty":-14.79951,"median":-6.24759,"eighty":21.052567,"marketCap":3272582391},{"date":"2024-02-23","current":22.345685,"twenty":-14.79951,"median":-6.24759,"eighty":21.629963,"marketCap":3208840411},{"date":"2024-03-01","current":22.245897,"twenty":-14.798622,"median":-6.243054,"eighty":21.891477,"marketCap":3194510819},{"date":"2024-03-08","current":23.543144,"twenty":-14.798622,"median":-6.243054,"eighty":22.245897,"marketCap":3380795518},{"date":"2024-03-15","current":22.287189,"twenty":-14.798622,"median":-6.243054,"eighty":22.345685,"marketCap":3200440305},{"date":"2024-03-22","current":23.539703,"twenty":-14.798622,"median":-6.243054,"eighty":22.455796,"marketCap":3380301394},{"date":"2024-03-28","current":24.152197,"twenty":-14.798622,"median":-6.243054,"eighty":22.668584,"marketCap":3468255443},{"date":"2024-04-05","current":26.4955,"twenty":-14.79951,"median":-6.24759,"eighty":23.333245,"marketCap":3804753799},{"date":"2024-04-12","current":27.142403,"twenty":-14.79951,"median":-6.24759,"eighty":23.547273,"marketCap":3897649086},{"date":"2024-04-19","current":27.314452,"twenty":-14.79951,"median":-6.24759,"eighty":24.616728,"marketCap":3922355280},{"date":"2024-04-26","current":28.129963,"twenty":-14.798622,"median":-6.243054,"eighty":26.60217,"marketCap":4039462637},{"date":"2024-05-03","current":37.595563,"twenty":-14.798622,"median":-6.243054,"eighty":26.863684,"marketCap":4936297461},{"date":"2024-05-10","current":40.090886,"twenty":-14.798622,"median":-6.243054,"eighty":27.665431,"marketCap":5263933317},{"date":"2024-05-17","current":41.553064,"twenty":-14.798622,"median":-6.243054,"eighty":28.811276,"marketCap":5455917314},{"date":"2024-05-24","current":40.922098,"twenty":-14.798622,"median":-6.243054,"eighty":29.413584,"marketCap":5373071507},{"date":"2024-05-31","current":41.911997,"twenty":-14.798622,"median":-6.243054,"eighty":30.154177,"marketCap":5503045169},{"date":"2024-06-07","current":40.249572,"twenty":-14.798622,"median":-6.243054,"eighty":30.439345,"marketCap":5284768790},{"date":"2024-06-14","current":39.550598,"twenty":-14.79951,"median":-6.24759,"eighty":30.613205,"marketCap":5192993494},{"date":"2024-06-21","current":37.196755,"twenty":-14.800397,"median":-6.252126,"eighty":30.726352,"marketCap":4883933984},{"date":"2024-06-28","current":40.449819,"twenty":-14.80306,"median":-6.267822,"eighty":30.857897,"marketCap":5311061172},{"date":"2024-07-05","current":40.25335,"twenty":-14.80306,"median":-6.267822,"eighty":30.977484,"marketCap":5285264872},{"date":"2024-07-12","current":41.364152,"twenty":-14.80306,"median":-6.267822,"eighty":31.235054,"marketCap":5431113180},{"date":"2024-07-15","current":41.92711,"twenty":-14.80306,"median":-6.267822,"eighty":31.262651,"marketCap":5505029499},{"date":"2024-08-02","current":38.287475,"twenty":-14.910808,"median":-6.366387,"eighty":31.421793,"marketCap":7140614095},{"date":"2024-08-09","current":37.188911,"twenty":-14.910808,"median":-6.366387,"eighty":31.644408,"marketCap":6935731949},{"date":"2024-08-16","current":38.423418,"twenty":-14.910808,"median":-6.366387,"eighty":32.257102,"marketCap":7165967538},{"date":"2024-08-23","current":38.064546,"twenty":-14.910808,"median":-6.366387,"eighty":32.751042,"marketCap":7099037890},{"date":"2024-08-30","current":38.20381,"twenty":-14.910808,"median":-6.366387,"eighty":33.893553,"marketCap":7125010589},{"date":"2024-09-06","current":36.388024,"twenty":-14.910808,"median":-6.366387,"eighty":36.083622,"marketCap":6786366553},{"date":"2024-09-13","current":37.395009,"twenty":-14.910808,"median":-6.366387,"eighty":36.366599,"marketCap":6974169145},{"date":"2024-09-20","current":41.511325,"twenty":-14.910808,"median":-6.366387,"eighty":37.017881,"marketCap":7741862190},{"date":"2024-09-27","current":41.8086,"twenty":-14.910808,"median":-6.366387,"eighty":37.427756,"marketCap":7797303912},{"date":"2024-10-04","current":41.264936,"twenty":-14.910808,"median":-6.366387,"eighty":37.949925,"marketCap":7695910491},{"date":"2024-10-11","current":43.570823,"twenty":-14.910808,"median":-6.366387,"eighty":38.317621,"marketCap":8125958449},{"date":"2024-10-18","current":42.73524,"twenty":-14.910808,"median":-6.366387,"eighty":38.444308,"marketCap":7970122255},{"date":"2024-10-25","current":33.906751,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7710395266},{"date":"2024-10-31","current":34.976887,"twenty":-14.910808,"median":-6.366387,"eighty":38.759769,"marketCap":7953743991},{"date":"2024-11-08","current":38.315221,"twenty":-14.920651,"median":-6.373244,"eighty":38.775863,"marketCap":8712881178},{"date":"2024-11-15","current":37.699284,"twenty":-14.920651,"median":-6.373244,"eighty":38.959639,"marketCap":8572817127},{"date":"2024-11-22","current":39.610661,"twenty":-14.920651,"median":-6.373244,"eighty":39.15086,"marketCap":9007464289},{"date":"2024-11-29","current":42.532525,"twenty":-14.920651,"median":-6.373244,"eighty":39.285271,"marketCap":9671896246},{"date":"2024-12-06","current":42.712265,"twenty":-14.920651,"median":-6.373244,"eighty":39.549842,"marketCap":9712769029},{"date":"2024-12-13","current":38.834712,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8831013491},{"date":"2024-12-20","current":37.173217,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8453189468},{"date":"2024-12-27","current":38.499344,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8754750859},{"date":"2025-01-03","current":38.468657,"twenty":-14.920651,"median":-6.373244,"eighty":39.665021,"marketCap":8747772579},{"date":"2025-01-10","current":40.298932,"twenty":-14.930493,"median":-6.380101,"eighty":40.000208,"marketCap":9163977143},{"date":"2025-01-17","current":43.998937,"twenty":-14.930493,"median":-6.380101,"eighty":40.25335,"marketCap":10005358346},{"date":"2025-01-24","current":46.585434,"twenty":-14.930493,"median":-6.380101,"eighty":40.313802,"marketCap":10593527670},{"date":"2025-01-31","current":35.909437,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9652456751},{"date":"2025-02-07","current":35.32268,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9494736407},{"date":"2025-02-14","current":34.0368,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9149091839},{"date":"2025-02-21","current":38.652589,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":10389815982},{"date":"2025-02-28","current":36.887291,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":9915303930},{"date":"2025-03-07","current":34.577539,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9294442372},{"date":"2025-03-14","current":32.776935,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8810440080},{"date":"2025-03-21","current":34.596121,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9299437236},{"date":"2025-03-28","current":34.525509,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9280456754},{"date":"2025-04-04","current":30.9466,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":8318446005},{"date":"2025-04-11","current":31.173301,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8379383343},{"date":"2025-04-17","current":31.994629,"twenty":-14.930493,"median":-6.380101,"eighty":40.449819,"marketCap":8600156318},{"date":"2025-04-25","current":27.828327,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":9959758217},{"date":"2025-05-02","current":28.141532,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":10071854469},{"date":"2025-05-09","current":29.09428,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":10412842968},{"date":"2025-05-16","current":32.051276,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11471151800},{"date":"2025-05-23","current":31.433729,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11250131518},{"date":"2025-05-30","current":32.461584,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":11618000862},{"date":"2025-06-06","current":34.362907,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":12298484481},{"date":"2025-06-13","current":34.557629,"twenty":-14.943168,"median":-6.411473,"eighty":40.459973,"marketCap":12368175561},{"date":"2025-06-20","current":34.906739,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":12493121712},{"date":"2025-06-27","current":38.019512,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13607183409},{"date":"2025-07-03","current":38.886026,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13917308715},{"date":"2025-07-11","current":38.488236,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13774939794},{"date":"2025-07-18","current":39.8805,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":14273231018},{"date":"2025-07-25","current":37.966659,"twenty":-14.955843,"median":-6.442845,"eighty":40.470128,"marketCap":13588267258},{"date":"2025-08-01","current":34.686981,"twenty":-14.955843,"median":-6.442845,"eighty":40.426052,"marketCap":12414470350},{"date":"2025-08-08","current":33.705646,"twenty":-14.955843,"median":-6.442845,"eighty":40.271583,"marketCap":12673322934},{"date":"2025-08-15","current":32.677002,"twenty":-14.955843,"median":-6.442845,"eighty":40.001719,"marketCap":12286552914},{"date":"2025-08-22","current":31.995541,"twenty":-14.955843,"median":-6.442845,"eighty":39.753576,"marketCap":12030323426},{"date":"2025-08-29","current":32.158614,"twenty":-14.955843,"median":-6.442845,"eighty":39.567222,"marketCap":12091639043},{"date":"2025-09-05","current":31.85368,"twenty":-14.968517,"median":-6.445322,"eighty":39.417295,"marketCap":11976983824},{"date":"2025-09-12","current":32.240814,"twenty":-14.955843,"median":-6.442845,"eighty":39.274576,"marketCap":12122546102},{"date":"2025-09-19","current":32.712799,"twenty":-14.955843,"median":-6.442845,"eighty":39.110506,"marketCap":12300012440},{"date":"2025-09-26","current":30.811601,"twenty":-14.955843,"median":-6.442845,"eighty":38.928183,"marketCap":11585162078},{"date":"2025-10-03","current":32.740641,"twenty":-14.955843,"median":-6.442845,"eighty":38.799168,"marketCap":12310480960},{"date":"2025-10-10","current":33.251074,"twenty":-14.955843,"median":-6.442845,"eighty":38.735836,"marketCap":12502403826},{"date":"2025-10-17","current":31.569959,"twenty":-14.955843,"median":-6.442845,"eighty":38.513562,"marketCap":11870304621},{"date":"2025-10-24","current":36.181987,"twenty":-14.955843,"median":-6.366387,"eighty":38.489905,"marketCap":14968488025},{"date":"2025-10-31","current":38.399149,"twenty":-14.955843,"median":-6.295891,"eighty":38.495183,"marketCap":15885727771},{"date":"2025-11-07","current":38.027043,"twenty":-14.955843,"median":-6.239752,"eighty":38.495183,"marketCap":15731787611},{"date":"2025-11-14","current":39.102416,"twenty":-14.955843,"median":20.322393,"eighty":38.688522,"marketCap":16176669691},{"date":"2025-11-21","current":36.775852,"twenty":-14.955843,"median":21.192959,"eighty":38.754291,"marketCap":15214170050},{"date":"2025-11-28","current":38.359409,"twenty":-14.900966,"median":21.781366,"eighty":38.773158,"marketCap":15869287559},{"date":"2025-12-05","current":37.901803,"twenty":-14.800397,"median":21.953414,"eighty":38.773158,"marketCap":15679976036},{"date":"2025-12-12","current":38.77005,"twenty":-14.73513,"median":22.249338,"eighty":38.773158,"marketCap":16039169742},{"date":"2025-12-19","current":38.719473,"twenty":-14.492423,"median":22.359449,"eighty":38.776091,"marketCap":16018245837},{"date":"2025-12-26","current":40.27172,"twenty":-14.427742,"median":22.596876,"eighty":38.842047,"marketCap":16660410453},{"date":"2026-01-02","current":37.913846,"twenty":-14.298255,"median":22.686342,"eighty":38.86133,"marketCap":15684957918},{"date":"2026-01-09","current":38.686959,"twenty":-13.913325,"median":23.374537,"eighty":38.961041,"marketCap":16004794755},{"date":"2026-01-16","current":40.956924,"twenty":-13.791374,"median":23.56379,"eighty":39.008843,"marketCap":16943879550},{"date":"2026-01-23","current":40.312663,"twenty":-13.606078,"median":24.575436,"eighty":39.09025,"marketCap":16677348852},{"date":"2026-01-30","current":35.555907,"twenty":-13.458905,"median":26.60217,"eighty":39.137259,"marketCap":15463264160},{"date":"2026-02-06","current":39.931382,"twenty":-13.458905,"median":26.863684,"eighty":39.1688,"marketCap":17366157832},{"date":"2026-02-13","current":42.145274,"twenty":-13.458905,"median":27.461396,"eighty":39.319195,"marketCap":18328979661},{"date":"2026-02-20","current":43.977777,"twenty":-13.458905,"median":27.678372,"eighty":39.433377,"marketCap":19125935133},{"date":"2026-02-27","current":45.529678,"twenty":-13.458905,"median":28.129963,"eighty":39.548331,"marketCap":19800856799},{"date":"2026-03-06","current":45.239913,"twenty":-13.458905,"median":28.811276,"eighty":39.637841,"marketCap":19674838215},{"date":"2026-03-13","current":43.202399,"twenty":-13.458905,"median":29.078981,"eighty":39.900853,"marketCap":18788723349},{"date":"2026-03-20","current":43.311204,"twenty":-13.458905,"median":29.47538,"eighty":39.999099,"marketCap":18836042580},{"date":"2026-03-27","current":44.852797,"twenty":-13.458905,"median":30.141608,"eighty":40.055602,"marketCap":19506481371},{"date":"2026-04-02","current":46.307346,"twenty":-13.458905,"median":30.356554,"eighty":40.257326,"marketCap":20139064777},{"date":"2026-04-10","current":49.387096,"twenty":-13.458905,"median":30.531334,"eighty":40.31108,"marketCap":21478448067},{"date":"2026-04-17","current":48.808712,"twenty":-13.458905,"median":30.715313,"eighty":40.418388,"marketCap":21226908996},{"date":"2026-04-24","current":48.865978,"twenty":-13.458905,"median":30.931489,"eighty":40.502951,"marketCap":21251813855},{"date":"2026-05-01","current":44.406969,"twenty":-13.458905,"median":30.977484,"eighty":40.825699,"marketCap":21275379058},{"date":"2026-05-08","current":46.163751,"twenty":-13.458905,"median":31.173301,"eighty":41.109259,"marketCap":22117053325},{"date":"2026-05-15","current":44.550084,"twenty":-13.458905,"median":31.262651,"eighty":41.382988,"marketCap":21343945202},{"date":"2026-05-22","current":45.456476,"twenty":-13.458905,"median":31.45123,"eighty":41.50031,"marketCap":21778197451},{"date":"2026-05-29","current":47.913274,"twenty":-13.462311,"median":31.593823,"eighty":41.784397,"marketCap":22955249600},{"date":"2026-06-05","current":51.087719,"twenty":-13.458905,"median":31.685304,"eighty":41.87149,"marketCap":24476126183},{"date":"2026-06-12","current":58.329519,"twenty":-13.458905,"median":31.823788,"eighty":41.955468,"marketCap":27945672469},{"date":"2026-06-18","current":59.679773,"twenty":-13.458905,"median":31.901979,"eighty":42.130392,"marketCap":28592579137},{"date":"2026-06-26","current":62.144868,"twenty":-13.462311,"median":31.992434,"eighty":42.265924,"marketCap":29773606134},{"date":"2026-07-02","current":63.277339,"twenty":-13.462311,"median":32.021372,"eighty":42.335954,"marketCap":30316173017},{"date":"2026-07-10","current":61.284107,"twenty":-13.462311,"median":32.052576,"eighty":42.453334,"marketCap":29361215555},{"date":"2026-07-17","current":57.494684,"twenty":-13.462311,"median":32.107571,"eighty":42.564168,"marketCap":27545703292},{"date":"2026-07-24","current":62.383392,"twenty":-13.462311,"median":32.239489,"eighty":42.72605,"marketCap":29887883042},{"date":"2026-07-31","current":47.238844,"twenty":-13.465718,"median":32.328317,"eighty":42.770723,"marketCap":25027139620},{"date":"2026-08-07","current":52.258985,"twenty":-13.465718,"median":32.454268,"eighty":42.916987,"marketCap":27686810430},{"date":"2026-08-14","current":50.098303,"twenty":-13.465718,"median":32.553703,"eighty":43.216468,"marketCap":26542081192},{"date":"2026-08-21","current":45.749535,"twenty":-13.465718,"median":32.706377,"eighty":43.475372,"marketCap":24238103459},{"date":"2026-08-28","current":45.889848,"twenty":-13.465718,"median":32.784266,"eighty":43.750874,"marketCap":24312441308}],"updateTime":1788197684421},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRS\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642282822","title":"Caribou Biosciences Reports Dose Escalation Durability Data for CB-011 at the 2026 European Hematology Association (EHA) Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642282822","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642282822?lang=en_us&edition=fundamental","pubTime":"2026-06-11 20:00","pubTimestamp":1781179200,"startTime":"0","endTime":"0","summary":"-- Single dose of CB-011 produced deep, durable responses in heavily pretreated, BCMA-nave patients with r/r MM: 83% CR rate, 91% MRD negativity, and 50% of patients in ≥CR at 15 months -- -- Case stu","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310377/0/en/Caribou-Biosciences-Reports-Dose-Escalation-Durability-Data-for-CB-011-at-the-2026-European-Hematology-Association-EHA-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","IE00B7SZL793.SGD","BK4559","EPV","BK4107","BK4139","LU0417517546.SGD","ORR","IE00B19Z4B17.USD","LD","IE0031619046.USD","BK4187","LU0868494617.USD","CAR","BK4599","BK4230","LU0963586101.USD","BK4022","LU0256863811.USD","LU2065731478.USD","CRS","CRBU","BK4006","LU0314106906.USD","LU1506573853.SGD","BK4539","ALT","BK4585","IE00B66KJ199.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289252","title":"Purple Biotech Presents New Preclinical Data at EACR 2026 Highlighting IM1240's Anti-Tumor Activity, Favorable Safety and Pharmacokinetic Profile, and Broad Therapeutic Window","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289252","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289252?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:00","pubTimestamp":1781175600,"startTime":"0","endTime":"0","summary":"Non-human primate (NHP) toxicology study validates the CAPTN-3 masking strategy, with IM1240 showing an 8-fold longer half-life, 16-fold greater exposure, and a markedly improved cytokine-release safe","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310329/0/en/Purple-Biotech-Presents-New-Preclinical-Data-at-EACR-2026-Highlighting-IM1240-s-Anti-Tumor-Activity-Favorable-Safety-and-Pharmacokinetic-Profile-and-Broad-Therapeutic-Window.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LU2065731478.USD","BK4006","IE00B19Z4B17.USD","IE0031619046.USD","XBI","BK4187","TLS","PK","BK4097","NHP","BK4181","LU0963586101.USD","BK4218","BK4581","BK4585","BK4225","BK4588","CRS","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642401957","title":"Cellectis Presents Final Phase 1 Results of Lasme-cel and  Preliminary Results on Eti-cel at EHA 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2642401957","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642401957?lang=en_us&edition=fundamental","pubTime":"2026-06-11 14:40","pubTimestamp":1781160000,"startTime":"0","endTime":"0","summary":"NEW YORK, June  11, 2026  (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to de","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/11/3310207/0/en/Cellectis-Presents-Final-Phase-1-Results-of-Lasme-cel-and-Preliminary-Results-on-Eti-cel-at-EHA-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCT","ORR","IE0031619046.USD","BK4161","BK4187","IE00B19Z4B17.USD","CAR","LU2065731478.USD","BK4006","BK4080","BK4022","CLLS","CRS","CR","IE00B66KJ199.SGD","BK4139","BK4231","BK4230","LU0963586101.USD","IE00B7SZL793.SGD","ADC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642442360","title":"Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2642442360","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642442360?lang=en_us&edition=fundamental","pubTime":"2026-06-10 19:30","pubTimestamp":1781091000,"startTime":"0","endTime":"0","summary":"CLN-978 (CD19 TCE) EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) CLN-978 data from the first RA mul","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/10/3309602/0/en/Cullinan-Therapeutics-Shares-New-Clinical-Data-Across-Its-Portfolio-of-T-Cell-Engager-Programs-Targeting-CD19-and-BCMA-in-Autoimmune-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS","BK4187","CGEM","RA","BK4077","SLE","LU0963586101.USD","BK4006","IE00B7SZL793.SGD","LU2065731478.USD","IE0031619046.USD","BK4139","IE00B19Z4B17.USD","ITP","IE00B66KJ199.SGD","BK4199"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642246411","title":"Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2642246411","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642246411?lang=en_us&edition=fundamental","pubTime":"2026-06-09 19:00","pubTimestamp":1781002800,"startTime":"0","endTime":"0","summary":"WestGene’s established targeted LNP platform combined with Cartesian’s mRNA payload from Descartes-08 integrates two independently, clinically tested technologies for rapid clinical translation Plans ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308695/0/en/Cartesian-Therapeutics-Announces-Strategic-Licensing-Agreement-with-WestGene-Biopharma-to-Accelerate-the-Development-of-In-Vivo-CAR-T-Platform-in-Autoimmune-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4006","IE00B19Z4B17.USD","BK4187","LU0963586101.USD","RNAC","IE00B7SZL793.SGD","BK4022","AAQC","CAR","CRS","BK4230","BK4139","IE0031619046.USD","IE00B66KJ199.SGD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641450485","title":"Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2641450485","media":"GlobeNewswire","labels":["policyRegulatory","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641450485?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:30","pubTimestamp":1780914600,"startTime":"0","endTime":"0","summary":"Multiple EULAR presentations reinforce potential of AlloNK to drive deep B-cell depletion and meaningful clinical responses across refractory rheumatoid arthritis, Sjgren disease and systemic sclerosi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3307910/0/en/Artiva-Biotherapeutics-Highlights-AlloNK-Data-Presented-at-EULAR-2026-FDA-RMAT-Designation-in-Refractory-Rheumatoid-Arthritis-and-Webcast-Today.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RA","IE0031619046.USD","LABU","LU0963586101.USD","CRS","ARTV","BK4139","BK4585","BK4588","IE00B19Z4B17.USD","BK4187","IE00B7SZL793.SGD","BK4006","IE00B66KJ199.SGD","LU2065731478.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641483061","title":"Lyell Immunopharma Provides Update on Safety Profile of LYL273 in Relapsed or Refractory Metastatic Colorectal Cancer and Amends Phase 1 Trial to Phase 1/2 Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2641483061","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641483061?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:00","pubTimestamp":1780912800,"startTime":"0","endTime":"0","summary":"Gastrointestinal prophylaxis reduced Grade ≥ 2 diarrhea/colitis from 55% without prophylaxis to 10% with prophylaxisThe maximum tolerated dose has not yet been determinedNo difference is observed in G","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/08/3307886/0/en/Lyell-Immunopharma-Provides-Update-on-Safety-Profile-of-LYL273-in-Relapsed-or-Refractory-Metastatic-Colorectal-Cancer-and-Amends-Phase-1-Trial-to-Phase-1-2-Expansion.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B66KJ199.SGD","CAR","CRS","LABU","BK4505","IE00B7SZL793.SGD","GCC","BK4230","LU0963586101.USD","IE0031619046.USD","BK4139","BK4187","LU2065731478.USD","IE00B19Z4B17.USD","BK4022","BK4539","BK4585","LYEL","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641290111","title":"Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2641290111","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641290111?lang=en_us&edition=fundamental","pubTime":"2026-06-06 17:15","pubTimestamp":1780737300,"startTime":"0","endTime":"0","summary":"Clinical benefit, including remissions, demonstrated in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) patients following a single target dose of CLN-978 Deep, dose-dependent B ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/06/3307681/0/en/Cullinan-Therapeutics-Presents-Initial-Clinical-Data-for-CLN-978-a-CD19xCD3-T-Cell-Engager-at-the-EULAR-2026-Congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4187","IE0031619046.USD","LU0963586101.USD","BK4139","BK4006","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4077","CGEM","SLE","CRS","RA","LU2065731478.USD","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157248","title":"Fate Therapeutics Showcases Data from FT819 and FT839 Programs at the European Congress of Rheumatology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157248","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640157248?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:30","pubTimestamp":1780576200,"startTime":"0","endTime":"0","summary":"FT819 off-the-shelf CAR T-cell therapy product candidate continues to broaden patient access with 21 SLE patients now treated, including as outpatient administration in community hospitals Continued d","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/04/3306754/24675/en/Fate-Therapeutics-Showcases-Data-from-FT819-and-FT839-Programs-at-the-European-Congress-of-Rheumatology-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SLE","EPV","IE00B7SZL793.SGD","LU2065731478.USD","BK4139","BK4187","FATE","CRS","LU0963586101.USD","CAR","BK4230","BK4077","BK4022","IE0031619046.USD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","BK4006"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640181557","title":"Carpenter Technology Director Steven E. Karol disposes of 2,000 common shares worth $975,478.80","url":"https://stock-news.laohu8.com/highlight/detail?id=2640181557","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640181557?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:11","pubTimestamp":1780517467,"startTime":"0","endTime":"0","summary":"Carpenter Technology: Director Steven E. Karol reported a sale of 2,000 common shares on June 1, 2026.Shares sold at an average price of $487.74.Indirect holdings through affiliates stood at 223,381 shares following the sale.Karol also reported direct ownership of 177,000 common shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carpenter Technology Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL4Ng2Ts:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Carpenter Technology Director Steven E. Karol disposes of 2,000 common shares worth $975,478.80","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","LU0963586101.USD","BK4187","BK4006","LU2065731478.USD","IE00B66KJ199.SGD","IE0031619046.USD","CRS","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640964152","title":"Carpenter Technology director John Anastasio Hart disposes of 250 common shares worth $115,470.33","url":"https://stock-news.laohu8.com/highlight/detail?id=2640964152","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640964152?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:17","pubTimestamp":1780345053,"startTime":"0","endTime":"0","summary":"Carpenter Technology director Anastasios John Hart exercised director stock options for 250 shares at USD 45.12 on May 28, 2026.He sold 250 shares the same day at an average USD 461.88, reducing his direct common stock holding to 0 shares.Hart reported 3,000 director stock options remaining after the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Carpenter Technology Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL5TnwQp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Carpenter Technology director John Anastasio Hart disposes of 250 common shares worth $115,470.33","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z4B17.USD","IE00B66KJ199.SGD","BK4006","CRS","LU0963586101.USD","LU2065731478.USD","BK4187","IE00B7SZL793.SGD","IE0031619046.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640570849","title":"Legend Biotech Presents First-in-Human LB2102 Results in Solid Tumors and New CARVYKTI® Data in Multiple Myeloma at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640570849","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640570849?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:00","pubTimestamp":1780322400,"startTime":"0","endTime":"0","summary":"LB2102 demonstrated a manageable safety profile and encouraging clinical activity in solid tumors among heavily pretreated patientsResponses observed at higher dose levels of LB2102 with an ORR of 28.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304508/0/en/Legend-Biotech-Presents-First-in-Human-LB2102-Results-in-Solid-Tumors-and-New-CARVYKTI-Data-in-Multiple-Myeloma-at-ASCO-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4505","BK4086","BK4230","LU2065731478.USD","LU1620156130.USD","SG9999001440.SGD","LU1596574779.USD","PML","IE00B7SZL793.SGD","EC","IEC","LU2413666004.HKD","MAS","ORR","BK4588","LU1721427968.SGD","XBI","LU0170899867.USD","LU1620156213.USD","CAR","LU1543694498.USD","LEGN","LU0963586101.USD","IE00B66KJ199.SGD","LU1165135440.EUR","BK4139","IE00B19Z4B17.USD","BK4187","BK4581","BK4006","BK4585","IE0031619046.USD","BK4201","LU2413665964.HKD","CRS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951863","title":"Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951863","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951863?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315200,"startTime":"0","endTime":"0","summary":"One-time infusion of anzu-cel (anzutresgene autoleucel, IMA203) PRAME cell therapy induced rapid, deep and durable systemic anti-tumor activity in metastatic PD-1 relapsed cutaneous melanoma and metas","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304266/0/en/Immatics-Presents-Clinical-Activity-and-Response-Dynamics-of-Anzu-cel-PRAME-Cell-Therapy-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PD","BK4139","LU1169590202.USD","CRS","BK4023","IE00B7SZL793.SGD","BK4187","IE0031619046.USD","IMTX","LU2065731478.USD","IE00B19Z4B17.USD","LU1169589451.USD","LU0963586101.USD","BK4006","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639048566","title":"Eikon Therapeutics Presents Data on Clinical-Stage Programs at the 2026 Annual Meeting of the American Society of Clinical Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2639048566","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639048566?lang=en_us&edition=fundamental","pubTime":"2026-05-31 02:30","pubTimestamp":1780165800,"startTime":"0","endTime":"0","summary":"TeLuRide-005, a Phase 2 trial of EIK1001 in first-line patients with stage 4 NSCLC completed enrollment of both non-squamous and squamous cohorts and reports updated rates of response and disease cont","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303899/0/en/Eikon-Therapeutics-Presents-Data-on-Clinical-Stage-Programs-at-the-2026-Annual-Meeting-of-the-American-Society-of-Clinical-Oncology.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZL793.SGD","LU2065731478.USD","BK4006","EIKN","IE00B19Z4B17.USD","LU0210528500.USD","SSI","LU2487616109.SGD","IE0031619046.USD","BK4187","ORR","AFG","BK4139","BK4107","LU0963586101.USD","BK4585","BK4588","BK4117","CRS","LU0053666078.USD","L","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639095506","title":"Immatics Presents Clinical Activity of IMA203CD8 PRAME Cell Therapy in Hard-to-Treat Gynecologic Cancers at 2026 ASCO Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2639095506","media":"GlobeNewswire","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639095506?lang=en_us&edition=fundamental","pubTime":"2026-05-30 20:00","pubTimestamp":1780142400,"startTime":"0","endTime":"0","summary":"One-time infusion of IMA203CD8 PRAME cell therapy in the ongoing Phase 1 dose escalation/dose expansion trial achieved anti-tumor activity in platinum-resistant ovarian cancer and in uterine cancer wi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/30/3303876/0/en/Immatics-Presents-Clinical-Activity-of-IMA203CD8-PRAME-Cell-Therapy-in-Hard-to-Treat-Gynecologic-Cancers-at-2026-ASCO-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS","ORR","IE00B66KJ199.SGD","LU0963586101.USD","BK4139","IE00B19Z4B17.USD","IMTX","IE0031619046.USD","LU2065731478.USD","BK4006","IE00B7SZL793.SGD","BK4187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638667234","title":"PeproMene Bio Announces Oral Presentation at EHA 2026 Highlighting Favorable Safety and Durable Responses with PMB-CT01 (BAFF-R CAR T-Cell Therapy) in B-cell Lymphomas, Including After Prior CD19 CAR T-Cell Failure","url":"https://stock-news.laohu8.com/highlight/detail?id=2638667234","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638667234?lang=en_us&edition=fundamental","pubTime":"2026-05-28 19:00","pubTimestamp":1779966000,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., May 28, 2026 /PRNewswire/ -- PeproMene Bio, Inc. announced today that updated clinical data from its ongoing Phase 1 study evaluating PMB-CT01, an investigational B-cell activating factor receptor -targeted CAR T-cell therapy, have been selected for an oral presentation at the 2026 Congress of the European Hematology Association .\"When cancer progresses following CD19 CAR T therapy, patients face a significant unmet medical need, with very limited treatment options remaining,\" said Larry W. Kwak, M.D., Ph.D., scientific founder of PeproMene Bio. \"These durable CRs clinically validate BAFF-R as a novel target, while the favorable safety profile observed to date may support future use in outpatient community oncology settings and further exploration in refractory autoimmune diseases.\". PeproMene Bio, Inc. is a clinical-stage biotech company in Irvine, California developing novel therapies to treat cancers and immune disorders. For more information, c","market":"other","thumbnail":"https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pepromene-bio-announces-oral-presentation-at-eha-2026-highlighting-favorable-safety-and-durable-responses-with-pmb-ct01-baff-r-car-t-cell-therapy-in-b-cell-lymphomas-including-after-prior-cd19-car-t-cell-failure-302783633.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CR","IE00B66KJ199.SGD","BK4022","IE00B19Z4B17.USD","CRS.AU","IE00B7SZL793.SGD","MRD.AU","LU2065731478.USD","BK4187","CAR","IE0031619046.USD","LU0963586101.USD","BK4161","BK4006","BK7095","CRS","BK4230"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131606643","title":"Navigating the Pitfalls of Offshore Trusts as CRS 2.0 Implementation Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=1131606643","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131606643?lang=en_us&edition=fundamental","pubTime":"2026-05-27 12:51","pubTimestamp":1779857496,"startTime":"0","endTime":"0","summary":"The efficacy of an offshore trust hinges on the consistency between its foundational documents and its ongoing operations, ensuring it can withstand multi-dimensional scrutiny including financial...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","IE00B7SZL793.SGD","BK4006","LU2065731478.USD","BK4187","IE00B19Z4B17.USD","CRS","LU0963586101.USD","IE00B66KJ199.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637328009","title":"Carpenter Technology: This Stock Will Melt Up -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2637328009","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637328009?lang=en_us&edition=fundamental","pubTime":"2026-05-23 09:30","pubTimestamp":1779499800,"startTime":"0","endTime":"0","summary":"Earnings momentum, pricing power, and high barriers to entry underscore the investment case for the specialty alloys maker. By Todd Chanko. Founded in 1889, the Philadelphia-based company manufactures highly specialized, mission-critical alloys used in aerospace, defense, consumer, medical, and other industrial applications. Its investors presentation cites over 30 disparate product categories, ranging from engines, electric vehicles, weaponry, semiconductors, sporting goods, and orthopedics.Only three companies in the world -- all in the U.S. -- have the capabilities to produce these special alloys, so supply is limited. At the same time, demand for such alloys to build aerospace, defense, medical, and industrial gas turbines is growing. This supply/demand imbalance contributed to another quarter of record operating income for Carpenter. The company's adjusted earnings per share rose by 47% in its latest quarter to a record $2.77 on a 12% jump in sales over the same period, to $812 mi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1429558221.USD","BOEG","LU0787776722.HKD","BK4564","IE000M9KFDE8.USD","LU0320765646.SGD","BK4551","BOEU","BK4588","LU1162221912.USD","LU1585245621.USD","BK4187","LU1280957306.USD","BA","EADSY","LU0162691827.USD","IE00B3S45H60.SGD","BK4516","RTXG","LU0640476718.USD","LU1366192091.USD","IE00B66KJ199.SGD","LU0683600562.USD","BK4550","LU0072461881.USD","LU2065731478.USD","LU2326559502.SGD","IE00B19Z4B17.USD","LU0963586101.USD","LU1430594728.SGD","CRS","BOED","RTX","LU1929549753.HKD","LU1435385759.SGD","IE00B775SV38.USD","BK4006","IE00B7SZL793.SGD","IE0031619046.USD","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637693613","title":"Analysts’ Top Industrial Goods Picks: Carpenter Technology (CRS), Brambles (BMBLF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637693613","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637693613?lang=en_us&edition=fundamental","pubTime":"2026-05-22 09:10","pubTimestamp":1779412236,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Industrial Goods sector as 2 analysts just weighed in on Carpenter Technology (CRS) and Brambles (BMBLF...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-industrial-goods-picks-carpenter-technology-crs-brambles-bmblf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-industrial-goods-picks-carpenter-technology-crs-brambles-bmblf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4187","CRS","BMBLF","IE00B66KJ199.SGD","LU2065731478.USD","BK4006","IE00B19Z4B17.USD","LU0963586101.USD","IE0031619046.USD","IE00B7SZL793.SGD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637333705","title":"Carpenter Technology: This Stock Will Melt Up -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2637333705","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637333705?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:00","pubTimestamp":1779364800,"startTime":"0","endTime":"0","summary":"Dental implants. Cellphones. Golf clubs. Boeing planes. No, these aren't clues frustrating fans of the popular Connections puzzle. They are, nonetheless, connected: Each one began in the heat of Carpenter Technology's high-tech furnaces.Founded in 1889, the Philadelphia-based company manufactures highly specialized, mission-critical alloys used in aerospace, defense, consumer, medical, and other industrial applications. Its investors presentation cites over 30 disparate product categories, ranging from engines, electric vehicles, weaponry, semiconductors, sporting goods, and orthopedics.Only three companies in the world -- all in the U.S. -- have the capabilities to produce these special alloys, so supply is limited. At the same time, demand for such alloys to build aerospace, defense, medical, and industrial gas turbines is growing. This supply/demand imbalance contributed to another quarter of record operating income for Carpenter. The company's adjusted earnings per share rose by 47","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU0683600562.USD","LU1429558221.USD","BK4566","LU0072461881.USD","LU1929549753.HKD","LU2326559502.SGD","BK4551","LU1280957306.USD","BK4006","IE00B775SV38.USD","LU0320765646.SGD","IE00B3S45H60.SGD","LU2065731478.USD","BOED","BA","IE00B66KJ199.SGD","LU1366192091.USD","LU1435385759.SGD","BK4516","LU0640476718.USD","LU1585245621.USD","EADSY","BK4588","LU0963586101.USD","LU1430594728.SGD","RTX","LU0787776722.HKD","BK4585","IE00B7SZL793.SGD","RTXG","BK4564","IE00B19Z4B17.USD","BOEG","BK4187","BOEU","IE0031619046.USD","LU0162691827.USD","CRS","BK4550","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":181,"code":"91000000","status":"200"}]}}